General Topics

What General Topics does

General Topics S.r.l. is a privately-held Italian dermatological research and product company founded in 1992 by Dr. Gianfranco de Paoli Ambrosi and headquartered in Salò (Brescia), Italy, with secondary manufacturing in San Felice del Benaco and wholly-owned sales subsidiaries in Germany (General Topics Deutschland) and Poland (General Topics Polonia). The company is built on skin biomechanics and wound-healing research that began in 1987 and protects that science with over 90 internationally extended patents and more than 30 filed patents. All products are developed and produced in Italy.

The company operates three brand-portfolio business units. SYNCHROLINE offers scientific dermocosmetics for dermatological conditions (including Terproline, Aknicare Combi, Synchroelast Body Cream, and Synchrovit C Serum). TEBITECH serves aesthetic medicine and plastic surgery through Enerpeel chemo-exfoliation medical devices (17 SKU references differentiated by organic-acid type and concentration, professional use only) and Tebiskin dermocosmetics designed to complement aesthetic procedures. FILLAST provides 'technological luxury cosmetics' targeting visible signs of aging, expression lines, and hydration. Across these units, General Topics has developed and marketed more than 150 products.

General Topics sells through a multi-channel go-to-market: direct-to-consumer e-commerce (registered user shop), pharmacy resellers, dermatology and aesthetic-medicine professionals (with a dedicated 'Doctor' and 'Medical representative' contact workflow), and direct subsidiaries in Germany and Poland. Brands are present in more than 45 countries across Europe, the Middle East, Asia Pacific, North America, Oceania, and Africa. The company operates under Confindustria Dispositivi Medici and is certified to ISO 9001:2015, ISO 13485:2016 / EN ISO 13485:2016, and ISO 22716:2007 GMP by BSI, with medical devices additionally certified to MDD 93/42/CEE by the Italian National Institute of Health. Headcount is reported at 11-50; no revenue, funding, or external investor information is disclosed in the source data.

Name

General Topics

Legal name

General Topics S.r.l.

Website

https://general-topics.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

11–50 employees

Short description

General Topics S.r.l. is an Italian privately-held dermatology and dermocosmetics company operating three brand units — SYNCHROLINE, TEBITECH (Enerpeel/Tebiskin), and FILLAST — selling 150+ patented products across 45+ countries via pharmacies, medical channels, and e-commerce.

Ownership category

akta.pro rank

Product category

Skincare and Dermocosmetics

NAICS

Soap and Cleaning Compound Manufacturing (32561), Medical Equipment and Supplies Manufacturing (3391)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

akta.pro secondary industries

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK), Professional/Backbar Skincare (Esthetician & Spa Use) (CRABAAAK), Sensitive Skin & Barrier Repair (CRABAAAG)

Keywords

• Dermocosmetics products
• Aesthetic medicine devices
• Skincare formulations
• Dermatological research
• Medical device manufacturing

Headquarters

HQ city

Salò

HQ country

Italy

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Distribution channels4 records

Marketing channels3 records

Core offering

General Topics develops, manufactures, and markets dermatological and cosmetic products across three business units: SYNCHROLINE (scientific dermocosmetics for skin conditions), TEBITECH (aesthetic medicine medical devices including the Enerpeel chemo-exfoliation line and Tebiskin dermocosmetics), and FILLAST (technological luxury anti-aging cosmetics). The company sells through an online shop, pharmacies, and medical professionals, distributing in over 45 countries.

Product overview

General Topics is a dermatological and dermocosmetics company founded in 1992 by Dr. Gianfranco de Paoli Ambrosi, structured around three distinct business units: SYNCHROLINE (Scientifically Proven Skin Solutions) offering dermocosmetics for dermatological conditions including Terproline, Aknicare Combi, Synchroelast Body Cream, and Synchrovit C Serum; TEBITECH (Technology and Biotechnologies for Dermatology and Plastic Surgery) encompassing Enerpeel chemo exfoliation medical devices and Tebiskin dermocosmetics for aesthetic procedures; and FILLAST (Technological Luxury Cosmetics) providing anti-aging luxury cosmetics. The company has developed over 150 products and holds over 90 international patents with more than 30 filed patents. All products are developed and manufactured in Italy.

Differentiator

Problem solved

Functional benefit

Brands

• Synchroline: Product range solving problems in dermocosmetics and dermatological field, characterized by scientific nature, completeness and simplicity of management. Website: synchroline.com
• Tebitech
• Fillast
• Enerpeel
• Tebiskin

Products and services

• SYNCHROLINE Scientific dermocosmetics and dermatological product range characterized by scientific rigor, completeness, and simplicity of management; addresses a wide range of skin conditions and diseases for patients and dermatology consumers.
• TEBITECH Enerpeel Chemo-exfoliation medical devices for exclusive professional use, comprising 17 references that differ in type and concentration of organic acid used for peeling treatments by dermatologists and aesthetic medicine practitioners.
• TEBITECH Tebiskin Dermocosmetics suited for different skin conditions, specially designed to be combined with different aesthetic medicine procedures; suitable for both professional and home use.
• FILLAST Technological luxury cosmetics addressing visible signs of aging, reducing expression lines and wrinkles, and maintaining proper hydration levels over time; positioned as affordable luxury skincare.

Quantifiable outcome

• Over 150 products developed and marketed
• +2 more outcomes

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Galderma: Global dermatology-focused company offering prescription and aesthetic dermatology products as well as consumer skincare; comparable to General Topics across its prescription-adjacent dermocosmetics (SYNCHROLINE) and aesthetic-medicine (TEBITECH/Enerpeel) lines, but at substantially larger scale.
• La Roche-Posay (L'Oréal): L'Oréal's dermatological skincare brand distributed through pharmacies and recommended by dermatologists; directly comparable to SYNCHROLINE in positioning, target consumer (sensitive / problem-prone skin), and pharmacy distribution model.
• Pierre Fabre Dermatologie: Dermatology division of Pierre Fabre Group offering dermo-cosmetic brands (Avene, Ducray) and medical dermatology products; comparable to General Topics in dermocosmetic positioning, pharmacy-channel distribution, and skin-condition-focused product ranges.
• Vichy (L'Oréal): L'Oréal dermatological skincare brand sold through pharmacies and focused on sensitive/problem-prone skin; comparable to SYNCHROLINE in pharmacy-channel, dermatology-endorsed positioning.

Emerging players

• Teoxane: Swiss aesthetics company offering dermal fillers and complementary skincare (CosmoSkin); partially comparable to General Topics' aesthetic-medicine (TEBITECH) and adjacent luxury-skincare (FILLAST) positioning.

Direct peers

• Sesderma: Spanish dermocosmetic laboratory developing nanotech-based skincare sold through pharmacies and aesthetic-medicine channels; highly comparable to General Topics in scientific positioning, professional-and-home dual channel, and Iberian/European distribution focus.
• ISDIN: Spanish dermocosmetic laboratory developing dermatology and aesthetic-medicine products distributed in pharmacies across Europe, Latin America, and Asia; comparable to General Topics in science-driven dermocosmetic development, pharmacy distribution, and aesthetic-medicine adjacency.
• Cantabria Labs: Spanish dermatology laboratory (formerly IFC) with dermocosmetic brands (Biretix, Endocare, Heliocare) sold via pharmacy and dermatology channels; directly comparable to General Topics in science-led dermocosmetic development and professional aesthetic-medicine adjacency.
• Sinclair Pharma: Specialty pharmaceutical and aesthetic-medicine company offering medical devices and dermatology/aesthetics products; comparable to TEBITECH's Enerpeel/Tebiskin franchise in medical-device-led aesthetics.
• Bioderma (NAOS): French dermo-cosmetic brand with strong pharmacy distribution and dermatology-led product development; comparable to SYNCHROLINE in scientific positioning, pharmacy channel presence, and skin-condition-focused portfolio (eczema, acne, sensitive skin).

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/generaltopics

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about General Topics